首页|关节镜清除术联合关节腔注射复方倍他米松对重度膝关节炎患者的疗效及炎症因子影响

关节镜清除术联合关节腔注射复方倍他米松对重度膝关节炎患者的疗效及炎症因子影响

扫码查看
目的:分析关节镜清除术联合关节腔注射复方倍他米松对重度膝关节炎患者的疗效及炎症因子影响。方法:回顾性分析本院 2019年 3 月-2021 年 3 月收治的 70 例重度膝关节炎患者的临床资料。根据治疗方法的不同分为对照组(n=35)与研究组(n=35),对照组采用单纯行关节镜清除术,研究组采用关节镜清除术联合关节腔注射复方倍他米松。比较 2 组临床疗效。结果:治疗 5 周后,2 组肿瘤因子-α、C反应蛋白及白细胞介素-1β水平均较治疗前降低,且研究组上述指标均低于对照组,差异有统计学意义(P<0。05)。治疗 5 周后,2 组疼痛视觉模拟(VAS)评分均较治疗前降低,且研究组VAS评分低于对照组,2 组Lysholm评分均较治疗前升高,且研究组Lysholm评分高于对照组,差异有统计学意义(P<0。05)。2 组并发症发生率比较,差异无统计学意义(P>0。05)。结论:关节镜清除术联合关节腔注射复方倍他米松应用于重度膝关节炎患者的治疗中,可改善炎症水平及膝关节功能,降低疼痛程度,且具有一定安全性。
Effect of Arthroscopic Clearance Combined with Joint Cavity Injection of Compound Betamethasone on Patients with Severe Knee Arthritis and the Influence of Inflammatory Factors
Objective:To analyze the effect of arthroscopic clearance combined with joint cavity injection of Compound Betamethasone on patients with severe knee arthritis and the influence of inflammatory factors.Methods:The clinical data of 70 patients with severe knee arthritis admitted to our hospital from March 2019 to March 2021 were retrospectively analyzed.According to different treatment methods,they were divided into a control group(n=35)and a study group(n=35).The control group received arthroscopic clearance alone,and the study group received arthroscopic clearance combined with joint cavity injection of Compound Betamethasone.The clinical efficacy of the two groups was compared.Results:After 5 weeks of treatment,the tumor factor-α,C-reactive protein and interleukin-1β in the two groups were lower than those before treatment,and the above indexes in the study group were lower than those in the control group,the differences were statistically significant(P<0.05).After 5 weeks of treatment,the pain Visual Analogue Scale(VAS)score of two groups was lower than before treatment,the VAS score of the study group was lower than that of the control group,the Lysholm score of two groups was higher than that before treatment,the Lysholm score of the study group was higher than that of the control group,the differences were statistically significant(P<0.05).There was no significant difference in the total incidence of complications between the two groups(P>0.05).Conclusion:Using arthroscopic clearance combined with joint cavity injection of Compound Betamethasone in treatment on patients with severe knee arthritis can improve the level of inflammation and knee function,reduce the degree of pain,and have a certain safety.

Severe knee arthritisJoint cavity injectionCompound BetamethasoneArthroscopic clearanceInflammatory factors

杜超、王海川、李振华、桑原田

展开 >

大连市第五人民医院骨外一科,辽宁 大连 116000

重度膝关节炎 关节腔注射 复方倍他米松 关节镜清除术 炎症因子

2024

中国伤残医学
中国康复医学会,黑龙江省截瘫研究所

中国伤残医学

影响因子:0.451
ISSN:1673-6567
年,卷(期):2024.32(6)